Clinical Trials for Gemcitabine

4 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TherapeuticECOGGIR0848
09/12/2012
A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma
TherapeuticVICCGI1173
07/31/2012
A Phase 1 Study of Gemcitabine, Dasatinib and Erlotinib in Patients with Advanced Pancreatic Carcinoma
TherapeuticACOSOGGIZ5041
04/14/2009
A Phase II Study of Preoperative Gemcitabine and Erlotinib Plus Pancreatomy and Postoperative Gemcitabine and Erlotinib for Patients with Operable Pancreatic Adenocarcinoma.
TherapeuticECOGTHOE1505
08/30/2007
A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (>=4 cm)-IIIA Non-Small Cell Lung Cancer (NSCLC).

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.